{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "R",
          "alt": "G",
          "position": "1441"
        },
        "variant_string_id": "LRRK2 R1441G"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "LRRK2 mutations are the cause of the most common inherited and some sporadic forms of Parkinson’s disease (PD).",
          "judgment": "Yes",
          "reasoning": "The paper explicitly states the role of LRRK2 mutations in causing Parkinson's disease."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "We investigated phosphorylation sites and binding proteins of LRRK2 purified from mouse brain.",
          "judgment": "Yes",
          "reasoning": "Protein-protein interaction and phosphorylation assays are commonly used to elucidate mechanisms underlying Parkinson’s disease.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates.",
          "extracted_paper_info": "Using affinity purification and mass spectrometric analysis, we investigated phosphorylation sites and binding proteins of LRRK2 purified from mouse brain.",
          "judgment": "No",
          "reasoning": "The paper describes a purification and mass spectrometry analysis of LRRK2. While this is a valid method, the paper does not explicitly state whether normal and abnormal controls were used in this purification or mass spectrometry. It does not mention replicates."
        },
        {
          "step_name": "Step 3b: Accepted/Validated Assay (if basic controls/replicates were insufficient in 3a).",
          "extracted_paper_info": "We investigated phosphorylation sites and binding proteins of LRRK2 purified from mouse brain.",
          "judgment": "No",
          "reasoning": "While affinity purification and mass spectrometry are accepted techniques, it is not specifically validated for the effect of the specific R1441G mutation. The study also lacked explicit controls and replication.",
          "next_step_or_outcome": "Do not use PS3/BS3"
        }
      ],
      "final_evidence_strength": {
        "type": "N/A",
        "strength": "N/A"
      },
      "overall_conclusion": "Due to the lack of explicit controls and replication details, and the absence of validation of the assay for the R1441G variant, the functional evidence is not applicable."
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "Y",
          "alt": "C",
          "position": "1699"
        },
        "variant_string_id": "LRRK2 Y1699C"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "LRRK2 mutations are the cause of the most common inherited and some sporadic forms of Parkinson’s disease (PD).",
          "judgment": "Yes",
          "reasoning": "The paper explicitly states the role of LRRK2 mutations in causing Parkinson's disease."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "We investigated phosphorylation sites and binding proteins of LRRK2 purified from mouse brain.",
          "judgment": "Yes",
          "reasoning": "Protein-protein interaction and phosphorylation assays are commonly used to elucidate mechanisms underlying Parkinson’s disease.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates.",
          "extracted_paper_info": "Using affinity purification and mass spectrometric analysis, we investigated phosphorylation sites and binding proteins of LRRK2 purified from mouse brain.",
          "judgment": "No",
          "reasoning": "The paper describes a purification and mass spectrometry analysis of LRRK2. While this is a valid method, the paper does not explicitly state whether normal and abnormal controls were used in this purification or mass spectrometry. It does not mention replicates."
        },
        {
          "step_name": "Step 3b: Accepted/Validated Assay (if basic controls/replicates were insufficient in 3a).",
          "extracted_paper_info": "We investigated phosphorylation sites and binding proteins of LRRK2 purified from mouse brain.",
          "judgment": "No",
          "reasoning": "While affinity purification and mass spectrometry are accepted techniques, it is not specifically validated for the effect of the specific Y1699C mutation. The study also lacked explicit controls and replication.",
          "next_step_or_outcome": "Do not use PS3/BS3"
        }
      ],
      "final_evidence_strength": {
        "type": "N/A",
        "strength": "N/A"
      },
      "overall_conclusion": "Due to the lack of explicit controls and replication details, and the absence of validation of the assay for the Y1699C variant, the functional evidence is not applicable."
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "N/A",
          "alt": "N/A",
          "position": "N/A"
        },
        "variant_string_id": "LRRK2 - Phosphorylation"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "LRRK2 mutations are the cause of the most common inherited and some sporadic forms of Parkinson’s disease (PD).",
          "judgment": "Yes",
          "reasoning": "The paper explicitly states the role of LRRK2 mutations in causing Parkinson's disease."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "We investigated phosphorylation sites and binding proteins of LRRK2 purified from mouse brain.",
          "judgment": "Yes",
          "reasoning": "Protein-protein interaction and phosphorylation assays are commonly used to elucidate mechanisms underlying Parkinson’s disease.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates.",
          "extracted_paper_info": "Using affinity purification and mass spectrometric analysis, we investigated phosphorylation sites and binding proteins of LRRK2 purified from mouse brain.",
          "judgment": "No",
          "reasoning": "The paper describes a purification and mass spectrometry analysis of LRRK2. While this is a valid method, the paper does not explicitly state whether normal and abnormal controls were used in this purification or mass spectrometry. It does not mention replicates."
        },
        {
          "step_name": "Step 3b: Accepted/Validated Assay (if basic controls/replicates were insufficient in 3a).",
          "extracted_paper_info": "We investigated phosphorylation sites and binding proteins of LRRK2 purified from mouse brain.",
          "judgment": "No",
          "reasoning": "While affinity purification and mass spectrometry are accepted techniques, it is not specifically validated for the phosphorylation of LRRK2 in the context of the PD-causing mutations. The study also lacked explicit controls and replication.",
          "next_step_or_outcome": "Do not use PS3/BS3"
        }
      ],
      "final_evidence_strength": {
        "type": "N/A",
        "strength": "N/A"
      },
      "overall_conclusion": "Due to the lack of explicit controls and replication details, and the absence of validation of the assay for the phosphorylation of LRRK2 in the context of PD-causing mutations, the functional evidence is not applicable."
    }
  ]
}